Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
head and neck cancer
Biotech
Bicara CEO: ASCO data resonate more with 'people that matter'
"Our data is resonating far more with the people that matter, which are the head and neck oncologists," Bicara's CEO told Fierce.
Gabrielle Masson
Jun 2, 2025 4:26pm
ASCO: Chasing Merus, Bicara shares 2-year HNSCC survival data
Jun 1, 2025 3:36pm
Merus hails 'unprecedented' survival on solid tumor bispecific
May 23, 2025 7:35am
Immutep's LAG-3 agent posts 'impressive' survival data
May 5, 2025 10:37am
ALX Oncology doubles down as lead asset fails 2 phase 2 trials
Apr 25, 2025 2:25pm
'One of the lucky few': Bicara CEO on last year's $326M IPO
Apr 14, 2025 3:59pm
